<DOC>
	<DOCNO>NCT01236365</DOCNO>
	<brief_summary>Children type1 diabetes ( T1DM ) increase risk cardiovascular disease ( CVD ) due chronic increase blood sugar inflammation . If also increase cholesterol , create highly abnormal environment fully correct improve control blood sugar . CVD remain principal risk mortality T1DM , prevention treatment , compel child . This grant proposal encompass 3 separate , yet interrelate project address different aspect CVD risk child T1DM . Project # 1 : randomize control trial safety efficacy class drug call `` statin '' , low bad cholesterol body , child diabetes elevated bad cholesterol . We measure change concentration blood inflammatory marker 1st time , correlate level marker change blood sugar measure continuous glucose sensor , instrument measure blood sugar continuously small needle skin . Project # 2 : laboratory study investigate genetics concentration key molecule participate inflammatory cascade atheromatous plaque formation cause CVD . Expression level child T1DM compare healthy control 1st time . Project # 3 : examines use abdominal aortic MRI measure damage artery child T1DM healthy age-matched control . The result study likely provide important new data use statins child diabetes .</brief_summary>
	<brief_title>Statins Children With Type 1 Diabetes Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Project 1 T1DM diagnose clinically &gt; 1 year HbA1C stable insulin therapy Ages : 10 20 year gender BMI &lt; 85th percentile Fasting LDLC &gt; 100mg/dl Normal thyroid function Projects 2 3 T1DM diagnose clinically &gt; 3 year HbA1C &gt; 8 % stable insulin therapy Ages : 12 20 year gender BMI &lt; 85th percentile Fasting LDLC &gt; 100mg/dl Normal thyroid function Projects 1,2 3 Severe dyslipidemia ( LDLC &gt; 160 , TG &gt; 400 mg/dl ) Smoking Pregnancy Current use antiinflammatory immunomodulatory drug , lipid lowering , antidiabetic drug Patients hypertension and/or microalbuminuria allow use balanced randomization standardize treatment</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Children</keyword>
	<keyword>Statins</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Lipoproteins</keyword>
	<keyword>C reactive protein</keyword>
	<keyword>Continuous glucose monitor</keyword>
	<keyword>Adolescence</keyword>
	<keyword>Abdominal magnetic resonance imaging</keyword>
	<keyword>Toll like receptor</keyword>
	<keyword>Receptors advance glycation end product</keyword>
	<keyword>Nutrition</keyword>
</DOC>